H. Nagata

Production of fibrogenic cytokines by cord blood-derived cultured human mast cells.

M. Kurosawa, Y. Miyachi, F. Kurimoto, 2000, The Journal of allergy and clinical immunology.

Identification of a polymorphism in the transmembrane domain of the protooncogene c-kit in healthy subjects.

D. Metcalfe, A. Worobec, H. Nagata, 1996, Experimental and clinical immunogenetics.

Constitutive mRNA and immunoreactivity for IL‐2 in human nasal mucosa

M. Kaliner, K. Okubo, H. Nagata, 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

c-kit mutation in a population of patients with mastocytosis.

D. Metcalfe, T. Semere, A. Worobec, 1997, International archives of allergy and immunology.

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

Y. Suzuki, D. Metcalfe, S. Tannenbaum, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Nerve growth factor release with mast‐cell‐derived mediators in a patient with systemic mastocytosis after middle‐wave ultraviolet irradiation

H. Inamura, M. Kurosawa, Y. Miyachi, 1999, Allergy.

Elevated expression of the proto-oncogene c-kit in patients with mastocytosis

D. Metcalfe, T. Semere, A. Worobec, 1998, Leukemia.

Histo‐blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease

Y. Mizuno, K. Ihara, K. Yamamura, 2012, International journal of immunogenetics.

Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis.

M. Kurosawa, Y. Miyachi, H. Amano, 1999, The Journal of allergy and clinical immunology.